secwatch / observer
8-K filed June 27, 2023, 7:59 PM ET ticker GDRX CIK 0001809519
leadership confidence high sentiment neutral materiality 0.50

GoodRx CMO Babak Azad to depart July 7; Andrew Slutsky named as replacement

GoodRx Holdings, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Andrew Slutsky

Chief Marketing Officer
GDRX · GoodRx Holdings, Inc.
Effective
2023-07-07
Filed
June 27, 2023, 7:59 PM ET
Andrew Slutsky, currently Senior Vice President of Strategic Marketing Innovation of the Company, will assume an updated Chief Marketing Officer role
Departed

Babak Azad

Chief Marketing Officer
GDRX · GoodRx Holdings, Inc.
Effective
2023-07-07
Successor
Andrew Slutsky
Filed
June 27, 2023, 7:59 PM ET
determined that Babak Azad will no longer serve as Chief Marketing Officer, effective July 7, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Slutsky changed role as Chief Marketing Officer at GoodRx Holdings, Inc..

Action
will assume an updated Chief Marketing Officer role
Role
Chief Marketing Officer
Exact text from the filing
Andrew Slutsky, currently Senior Vice President of Strategic Marketing Innovation of the Company, will assume an updated Chief Marketing Officer role
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Babak Azad departed as Chief Marketing Officer at GoodRx Holdings, Inc..

Action
will no longer serve
Role
Chief Marketing Officer
Exact text from the filing
determined that Babak Azad will no longer serve as Chief Marketing Officer, effective July 7, 2023
View on SEC.gov

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-176254
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.